Toagosei operates in Japan, the United States, China, Taiwan, Hong Kong, Singapore, Thailand, Vietnam, Korea, and internationally, providing both commodity and specialty chemicals. Recent strategic initiatives include a share repurchase program, higher dividends for 2025 and 2026, and fresh earnings guidance for 2026.
Cyborg Score Rationale
Established 90+ year history with strong international presence and diversified chemical portfolio. 2024 revenue grew 5.16% to 167.59 billion, though earnings declined 2.48% to 11.88 billion. Recent shareholder return initiatives signal confidence but mixed earnings trends warrant monitoring.